206 related articles for article (PubMed ID: 16854434)
1. Prolonged relaxation consistent with persistent soluble guanylyl cyclase activation in canine pulmonary artery following brief treatment with nitric oxide donors.
Kwak YL; Jones KA; Warner DO; Perkins WJ
Life Sci; 2006 Oct; 79(21):2001-9. PubMed ID: 16854434
[TBL] [Abstract][Full Text] [Related]
2. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
Bawankule DU; Sathishkumar K; Sardar KK; Chanda D; Krishna AV; Prakash VR; Mishra SK
J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
El-Awady MS; Smirnov SV; Watson ML
Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)(2)(NO)](PF(6)) is due to activation of K(Ca) by a cGMP-dependent pathway.
Lunardi CN; Vercesi JA; da Silva RS; Bendhack LM
Vascul Pharmacol; 2007; 47(2-3):139-44. PubMed ID: 17602893
[TBL] [Abstract][Full Text] [Related]
6. Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.
Perkins WJ; Kost S; Danielson M
Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L666-73. PubMed ID: 19181745
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
[TBL] [Abstract][Full Text] [Related]
8. Prolonged exposure of canine coronary arteries to a nitric oxide donor desensitizes soluble guanylate cyclase.
Sorajja P; Cable DG; Hamner CE; Schaff HV
J Surg Res; 2005 Jan; 123(1):82-8. PubMed ID: 15652954
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
[TBL] [Abstract][Full Text] [Related]
10. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Sep; 79(1):66-70. PubMed ID: 9735242
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
[TBL] [Abstract][Full Text] [Related]
12. Calcium/calmodulin-dependent nitric oxide synthase activity in the CNS of Aplysia californica: biochemical characterization and link to cGMP pathways.
Bodnárová M; Martásek P; Moroz LL
J Inorg Biochem; 2005 Apr; 99(4):922-8. PubMed ID: 15811509
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylyl cyclase is localised in the acinar cells and participates in amylase secretion in rat parotid gland.
Shimomura H; Tanaka S; Komine N; Shimooka S; Imai A; Nashida T
Arch Oral Biol; 2004 Sep; 49(9):691-6. PubMed ID: 15275856
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
16. Non-lesional vitiliginous melanocytes are not characterized by an increased proneness to nitric oxide-induced apoptosis.
Ivanova K; van den Wijngaard R; Gerzer R; Lamers WH; Das PK
Exp Dermatol; 2005 Jun; 14(6):445-53. PubMed ID: 15885080
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide relaxes rat tail artery smooth muscle by cyclic GMP-independent decrease in calcium sensitivity of myofilaments.
Soloviev A; Lehen'kyi V; Zelensky S; Hellstrand P
Cell Calcium; 2004 Aug; 36(2):165-73. PubMed ID: 15193864
[TBL] [Abstract][Full Text] [Related]
18. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Kotikoski H; Kankuri E; Vapaatalo H
Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitric oxide donors and inhibitors of nitric oxide signalling on endothelin- and serotonin-induced contractions in human placental arteries.
Sand AE; Andersson E; Fried G
Acta Physiol Scand; 2002 Mar; 174(3):217-23. PubMed ID: 11906320
[TBL] [Abstract][Full Text] [Related]
20. Peroxynitrite has potent pulmonary vasodilator activity in the rat.
Casey DB; Pankey EA; Badejo AM; Bueno FR; Bhartiya M; Murthy SN; Uppu RM; Nossaman BD; Kadowitz PJ
Can J Physiol Pharmacol; 2012 Apr; 90(4):485-500. PubMed ID: 22452357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
